# | Title | Journal | Year | Citations |
---|
1 | Cardiovascular Protective Effects of Resveratrol | Cardiovascular Drug Reviews | 2004 | 450 |
2 | Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP Inhibitors | Cardiovascular Drug Reviews | 2007 | 282 |
3 | The Many Faces of H89: A Review | Cardiovascular Drug Reviews | 2006 | 275 |
4 | Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodilator Effects | Cardiovascular Drug Reviews | 2002 | 242 |
5 | C-Reactive Protein (CRP)-Lowering Agents | Cardiovascular Drug Reviews | 2006 | 228 |
6 | Prasugrel: A Novel Thienopyridine Antiplatelet Agent. A Review of Preclinical and Clinical Studies and the Mechanistic Basis for Its Distinct Antiplatelet Profile | Cardiovascular Drug Reviews | 2007 | 227 |
7 | Cardiovascular Actions of Berberine | Cardiovascular Drug Reviews | 2001 | 226 |
8 | Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent | Cardiovascular Drug Reviews | 1993 | 206 |
9 | A Review on Telmisartan: A Novel, Long‐Acting Angiotensin II‐Receptor Antagonist | Cardiovascular Drug Reviews | 2000 | 176 |
10 | Therapeutic Use of Citrulline in Cardiovascular Disease | Cardiovascular Drug Reviews | 2006 | 176 |
11 | Cilostazol (Pletal®): A Dual Inhibitor of Cyclic Nucleotide Phosphodiesterase Type 3 and Adenosine Uptake | Cardiovascular Drug Reviews | 2001 | 172 |
12 | Rosuvastatin: A Highly Effective New HMG‐CoA Reductase Inhibitor | Cardiovascular Drug Reviews | 2002 | 160 |
13 | Perhexiline | Cardiovascular Drug Reviews | 2007 | 152 |
14 | Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents — The Selective Factor Xa Inhibitors | Cardiovascular Drug Reviews | 2002 | 144 |
15 | Pharmacological Actions of Sodium Ferulate in Cardiovascular System | Cardiovascular Drug Reviews | 2005 | 142 |
16 | Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin-II Antagonist | Cardiovascular Drug Reviews | 1995 | 121 |
17 | Antiatherogenic Properties of Naringenin, a Citrus Flavonoid | Cardiovascular Drug Reviews | 1999 | 119 |
18 | Therapeutic Effects of Guggul and Its Constituent Guggulsterone: Cardiovascular Benefits | Cardiovascular Drug Reviews | 2007 | 113 |
19 | Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG‐CoA Reductase Inhibitor | Cardiovascular Drug Reviews | 2003 | 108 |
20 | Carvedilol: Molecular and Cellular Basis for Its Multifaceted Therapeutic Potential | Cardiovascular Drug Reviews | 2001 | 106 |
21 | Basic Experimental Studies and Clinical Aspects of Gadolinium Salts and Chelates | Cardiovascular Drug Reviews | 2001 | 103 |
22 | Trimetazidine, A Cellular Anti-ischemic Agent | Cardiovascular Drug Reviews | 1988 | 102 |
23 | Angiotensin‐(1‐7): Pharmacology and New Perspectives in Cardiovascular Treatments | Cardiovascular Drug Reviews | 2007 | 100 |
24 | Tolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical Trials | Cardiovascular Drug Reviews | 2007 | 97 |
25 | Ro 40?5967: A New Nondihydropyridine Calcium Antagonist | Cardiovascular Drug Reviews | 1991 | 96 |
26 | SR 90107A/Org 31540, a Novel Anti-Factor Xa Antithrombotic Agent | Cardiovascular Drug Reviews | 1997 | 96 |
27 | Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA) | Cardiovascular Drug Reviews | 2001 | 95 |
28 | Oxidative Stress as the Leading Cause of Acute Myocardial Infarction in Diabetics | Cardiovascular Drug Reviews | 2006 | 92 |
29 | Clinical Use and Molecular Mechanisms of Action of Extract of Ginkgo biloba Leaves in Cardiovascular Diseases | Cardiovascular Drug Reviews | 2004 | 91 |
30 | Pharmacological Mechanisms Contributing to the Clinical Efficacy of Levosimendan | Cardiovascular Drug Reviews | 2005 | 91 |
31 | Role of Adenosine as Adjunctive Therapy in Acute Myocardial Infarction | Cardiovascular Drug Reviews | 2006 | 91 |
32 | L-Dihydroxyphenylserine (L-DOPS): A Norepinephrine Prodrug | Cardiovascular Drug Reviews | 2006 | 87 |
33 | Cardiovascular Therapeutic Aspects of Soluble Epoxide Hydrolase Inhibitors | Cardiovascular Drug Reviews | 2006 | 86 |
34 | Pharmacodynamic, Pharmacokinetic and Clinical Effects of Clevidipine, an Ultrashort‐Acting Calcium Antagonist for Rapid Blood Pressure Control | Cardiovascular Drug Reviews | 2004 | 85 |
35 | Argatroban, A Selective, Potent Thrombin Inhibitor | Cardiovascular Drug Reviews | 1991 | 84 |
36 | Pharmacological Effects of Xanthones as Cardiovascular Protective Agents | Cardiovascular Drug Reviews | 2004 | 79 |
37 | Oxidative Stress and Cardiovascular Disease: Antioxidants and Unresolved Issues | Cardiovascular Drug Reviews | 2006 | 75 |
38 | The Novel Antiarrhythmic Drug Dronedarone: Comparison with Amiodarone | Cardiovascular Drug Reviews | 2005 | 75 |
39 | Therapeutic Potentials of Sarpogrelate in Cardiovascular Disease* | Cardiovascular Drug Reviews | 2004 | 73 |
40 | Pharmacology of Azimilide Dihydrochloride (NE-10064), A Class III Antiarrhythmic Agent | Cardiovascular Drug Reviews | 1997 | 70 |
41 | Ramatroban (BAY u 3405): A Novel Dual Antagonist of TXA2 Receptor and CRTh2, a Newly Identified Prostaglandin D2 Receptor | Cardiovascular Drug Reviews | 2004 | 70 |
42 | Therapeutic Potential of VIVIT, a Selective Peptide Inhibitor of Nuclear Factor of Activated T cells, in Cardiovascular Disorders | Cardiovascular Drug Reviews | 2007 | 69 |
43 | Cilostazol | Cardiovascular Drug Reviews | 1993 | 67 |
44 | Lectin-like Oxidized Low-density Lipoprotein Receptor-1, a New Promising Target for the Therapy of Atherosclerosis? | Cardiovascular Drug Reviews | 2007 | 67 |
45 | Sulodexide: A Renewed Interest in This Glycosaminoglycan | Cardiovascular Drug Reviews | 2006 | 65 |
46 | Pharmacological Effects of AVE 0991, a Nonpeptide Angiotensin-(1?7) Receptor Agonist | Cardiovascular Drug Reviews | 2006 | 64 |
47 | N‐(p‐Amylcinnamoyl)anthranilic Acid (ACA): A Phospholipase A2 Inhibitor and TRP Channel Blocker | Cardiovascular Drug Reviews | 2007 | 64 |
48 | Phosphomannopentaose Sulfate (PI‐88): Heparan Sulfate Mimetic with Clinical Potential in Multiple Vascular Pathologies | Cardiovascular Drug Reviews | 2004 | 63 |
49 | Ambrisentan, a Non-peptide Endothelin Receptor Antagonist | Cardiovascular Drug Reviews | 2006 | 61 |
50 | Oleamide: A Fatty Acid Amide Signaling Molecule in the Cardiovascular System? | Cardiovascular Drug Reviews | 2007 | 60 |